Market Place
Sourcing Support
Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy
09 Dec 2019 //
BUSINESSWIRE
Flemming Ornskov`s Galderma scores `breakthrough` status
09 Dec 2019 //
ENDPTS
Galderma Announces FDA Approval of Restylane Refyne & Restylane Defyne
12 Dec 2016 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.